Last week, the U.S. House of Representatives approved a bill aimed at allowing researchers to have access to the cannabis available commercially in states where legal recreational, and/or medical cannabis programs exist. This new legislation would mark a major shift from the current practice where researchers can only use the cannabis supplied by a federally licensed manufacturer in Mississippi.
The primary goal of the cannabis provision, which is found deeply embedded in an infrastructure bill detailed in a more than 2,000-page document, is to make it possible for marijuana products to be transported and distributed across state lines, including in states that don’t yet have state-legal marijuana markets in place.
The INVEST in America Act also contains provisions that would require states with cannabis programs to establish mechanisms for teaching residents to avoid driving while under the influence of cannabis.
The section on setting up highway safety education programs didn’t go down well with cannabis law reform advocates for a number of reasons. First, a congressional research team authored a report stating that there wasn’t any conclusive evidence that the consumption of cannabis resulted in impaired driving.
Read more at CNW420